WE-PHARMA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
What changed
WE-PHARMA
NACE 82.920, Office administrative, office support and other business support activities
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
-€2.2m
2024 · €4,235-€2.2m
Equity
€1.4m
2024 · €1.3m+€109,556
Cash
€24,738
2024 · €15,489+€9,249
Balance sheet total
€4.5m
2024 · €3.5m+€1.0m
Largest movements
Assets
- Intangible fixed assets +€921,295
new in 2025: €921,295
- Receivables within one year +€207,812
up €207,812 (+15.7%), from €1.3m to €1.5m
of which Other amounts receivable: +€427,794
- Deferred charges and accrued income -€52,186
down €52,186 (-98.7%), from €52,873 to €687
Equity and liabilities
- Contributions +€2.3m
up €2.3m (+200.1%), from €1.2m to €3.5m
- Profit (loss) carried forward -€2.2m
down €2.2m, from €99,543 to -€2.1m
- Debts after one year +€1.5m
up €1.5m (+333.1%), from €458,545 to €2.0m
- Other debts -€367,686
no longer reported in 2025 (was €367,686)
- Short-term financial debts -€250,000
down €250,000 (-24.4%), from €1.0m to €775,000
Income statement
- Turnover -€2.3m
no longer reported in 2025 (was €2.3m)
- Financial charges +€1.9m
up €1.9m (+824.3%), from €233,305 to €2.2m
of which Non-recurring financial charges: +€1.9m
- Purchases and services -€1.8m
no longer reported in 2025 (was €1.8m)
- Staff costs +€290,350
up €290,350 (+37.7%), from €769,515 to €1.1m
- Gross operating margin -€48,202
down €48,202 (-3.8%), from €1.3m to €1.2m
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Result 2024
€4,235
Gross operating margin
-€48,202
Staff costs
-€290,350
Depreciation
-€31,759
Write-downs
-€111
Other operating charges
+€8,320
Financial income
+€250
Financial charges
-€1.9m
Taxes
+€44,200
Result 2025
-€2.2m
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
From operations
-€2.5m
Investment
-€1.1m
Financing
+€3.6m
Cash 2024
€15,489
From operations (derived)
-€2.5m
Net result for the year
-€2.2m
Depreciation
+€241,893
Stocks and contracts
+€14,987
Receivables within one year
-€207,812
Deferred charges and accrued income
+€52,186
Trade debts
+€102,869
Tax, wage and social debts
-€63,369
Other debts
-€367,686
Accrued charges and deferred income
-€1,218
Investment (derived)
-€1.1m
Investment in fixed assets (net)
-€1.1m
Financing
+€3.6m
Debts after one year
+€1.5m
Current portion of long-term debt
-€9,841
Short-term financial debts
-€250,000
Contributions, distributions and other
+€2.3m
Cash 2025
€24,738
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €3,466,502 | €4,514,448 | +€1.0m | +30.2% |
| Fixed assets | 21/28 | €1,202,338 | €2,100,395 | +€898,057 | +74.7% |
| Intangible fixed assets | 21 | - | €921,295 | +€921,295 | |
| Tangible fixed assets | 22/27 | €1,201,905 | €1,178,667 | -€23,238 | -1.9% |
| Land and buildings | 22 | €456,289 | €466,668 | +€10,380 | +2.3% |
| Plant, machinery and equipment | 23 | €93,870 | €215,294 | +€121,424 | +129.4% |
| Furniture and vehicles | 24 | €651,747 | €496,705 | -€155,042 | -23.8% |
| Financial fixed assets | 28 | €433 | €433 | = | 0.0% |
| Current assets | 29/58 | €2,264,164 | €2,414,053 | +€149,889 | +6.6% |
| Stocks and contracts in progress | 3 | €874,701 | €859,714 | -€14,987 | -1.7% |
| Stocks | 30/36 | €874,701 | €859,714 | -€14,987 | -1.7% |
| Amounts receivable within one year | 40/41 | €1,321,102 | €1,528,914 | +€207,812 | +15.7% |
| Trade receivables | 40 | €692,624 | €472,642 | -€219,982 | -31.8% |
| Other amounts receivable | 41 | €628,477 | €1,056,272 | +€427,794 | +68.1% |
| Cash at bank and in hand | 54/58 | €15,489 | €24,738 | +€9,249 | +59.7% |
| Deferred charges and accrued income | 490/1 | €52,873 | €687 | -€52,186 | -98.7% |
| Total equity and liabilities | 10/49 | €3,466,502 | €4,514,448 | +€1.0m | +30.2% |
| Equity | 10/15 | €1,275,963 | €1,385,519 | +€109,556 | +8.6% |
| Contributions | 10/11 | €1,172,200 | €3,518,302 | +€2.3m | +200.1% |
| Reserves | 13 | €4,220 | €4,220 | = | 0.0% |
| Non-distributable reserves | 130/1 | €4,220 | €4,220 | = | 0.0% |
| Reserves not available under the articles | 1311 | €4,220 | €4,220 | = | 0.0% |
| Profit (loss) carried forward | 14 | €99,543 | -€2,137,003 | -€2.2m | |
| Amounts payable | 17/49 | €2,190,540 | €3,128,929 | +€938,390 | +42.8% |
| Amounts payable after more than one year | 17 | €458,545 | €1,986,179 | +€1.5m | +333.1% |
| Financial debts | 170/4 | €458,545 | €1,986,179 | +€1.5m | +333.1% |
| Amounts payable within one year | 42/48 | €1,730,777 | €1,142,750 | -€588,027 | -34.0% |
| Current portion of amounts payable after more than one year | 42 | €140,736 | €130,895 | -€9,841 | -7.0% |
| Financial debts | 43 | €1,025,000 | €775,000 | -€250,000 | -24.4% |
| Credit institutions | 430/8 | €1,025,000 | €775,000 | -€250,000 | -24.4% |
| Trade debts | 44 | €72,263 | €175,133 | +€102,869 | +142.4% |
| Suppliers | 440/4 | €72,263 | €175,133 | +€102,869 | +142.4% |
| Taxes, remuneration and social security | 45 | €125,091 | €61,722 | -€63,369 | -50.7% |
| Taxes | 450/3 | €40,725 | - | -€40,725 | |
| Remuneration and social security | 454/9 | €84,366 | €61,722 | -€22,644 | -26.8% |
| Other amounts payable | 47/48 | €367,686 | - | -€367,686 | |
| Accrued charges and deferred income | 492/3 | €1,218 | - | -€1,218 | |
| Turnover | 70 | €2,344,618 | - | -€2.3m | |
| Non-recurring operating income | 76A | €528,881 | - | -€528,881 | |
| Goods, raw materials, services and sundry goods | 60/61 | €1,802,494 | - | -€1.8m | |
| Remuneration, social security and pensions | 62 | €769,515 | €1,059,865 | +€290,350 | +37.7% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €210,134 | €241,893 | +€31,759 | +15.1% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | - | €111 | +€111 | |
| Other operating charges | 640/8 | €16,234 | €7,915 | -€8,320 | -51.2% |
| Gross operating margin | 9900 | €1,277,623 | €1,229,420 | -€48,202 | -3.8% |
| Operating profit (loss) | 9901 | €281,740 | -€80,363 | -€362,103 | |
| Financial income | 75/76B | €0 | €250 | +€250 | +192507.7% |
| Recurring financial income | 75 | €0 | €250 | +€250 | +192507.7% |
| Financial charges | 65/66B | €233,305 | €2,156,433 | +€1.9m | +824.3% |
| Recurring financial charges | 65 | €233,305 | €237,400 | +€4,095 | +1.8% |
| Non-recurring financial charges | 66B | - | €1,919,033 | +€1.9m | |
| Profit (loss) for the period before taxes | 9903 | €48,435 | -€2,236,546 | -€2.3m | |
| Income taxes | 67/77 | €44,200 | - | -€44,200 | |
| Profit (loss) for the period | 9904 | €4,235 | -€2,236,546 | -€2.2m | |
| Profit (loss) for the period to be appropriated | 9905 | €4,235 | -€2,236,546 | -€2.2m |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 5 October 2026 via checked.be.